Seroprevalence of Anti-SARS-CoV-2 Antibodies Three Months Post Infection in Healthcare Professionals at an Oncology Hospital in Northern Portugal

Abstract

N/a.

One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study

“…Given that seroprevalence was correlated to the local infection rate, it is difficult to compare our results to other regions in France or other countries [6][7][8][9][10][11][12][13][14][15][16]. Nevertheless, the rate of asymptomatic cases was similar to that reported in the literature [3].…”

“…Some studies focused on seroprevalence among health workers (HWs) in contact with cancer patients, especially after the first wave of the COVID-19 pandemic. They reported heterogeneous seroprevalence of SARS-CoV-2 from 1.8% to 18.4% between March and June 2020, as a result of variation in the performances of serological tests at the beginning of the pandemic crisis, disparities between countries in the prevalence of SARS-CoV-2 infection, and management of the COVID-19 crisis [7][8][9][10][11][12][13][14][15]. Out of them, four studies focused on health workers at French cancer centers, but the incidence rate of SARS-CoV-2 was also heterogeneous between regions [16].…”

Seroprevalence in health care workers during the later phase of the second wave: Results of three hospitals in Serbia, prior to vaccine administration

“…Contrary to our finding, the overall prevalence in three hospitals in Turkey was 2.7%, the highest 7.2% in one of these hospitals [12] . Low prevalence was also recorded in other counties such as Spain [13] , Greece [14] , and Portugal [15] , [16] . However, the organization of work in these hospitals was different than in our three hospitals.…”